227 related articles for article (PubMed ID: 20132502)
21. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
22. Preserved or slightly depressed ejection fraction and outcomes after myocardial infarction.
Badheka AO; Rathod A; Bharadwaj AS; Manickam P; Kizilbash MA; Veeranna V; Jacob S; Afonso L
Postgrad Med J; 2011 Jun; 87(1028):400-4. PubMed ID: 21441163
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
[TBL] [Abstract][Full Text] [Related]
25. Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.
Hsia J; Jablonski KA; Rice MM; Sabatine MS; Zabalgoitia M; Maggioni A; Cuddy TE; Domanski MJ; Geller NL; Flaker G; Solomon S; Omland T; Rouleau JL;
Am J Cardiol; 2008 Feb; 101(4):457-61. PubMed ID: 18312757
[TBL] [Abstract][Full Text] [Related]
26. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
27. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
28. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
29. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Tarasov NI; Kokov AN; Barbarash LS
Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
[TBL] [Abstract][Full Text] [Related]
30. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
31. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function.
De Ferrari GM; Sanzo A; Bertoletti A; Specchia G; Vanoli E; Schwartz PJ
J Am Coll Cardiol; 2007 Dec; 50(24):2285-90. PubMed ID: 18068036
[TBL] [Abstract][Full Text] [Related]
32. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
[TBL] [Abstract][Full Text] [Related]
33. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
34. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
[TBL] [Abstract][Full Text] [Related]
35. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
36. The impact of left ventricular systolic dysfunction on survival after renal transplantation.
Siedlecki A; Foushee M; Curtis JJ; Gaston RS; Perry G; Iskandrian AE; de Mattos AM
Transplantation; 2007 Dec; 84(12):1610-7. PubMed ID: 18165772
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
[TBL] [Abstract][Full Text] [Related]
38. Right and left bundle branch block as predictors of long-term mortality following myocardial infarction.
Lewinter C; Torp-Pedersen C; Cleland JG; Køber L
Eur J Heart Fail; 2011 Dec; 13(12):1349-54. PubMed ID: 22027083
[TBL] [Abstract][Full Text] [Related]
39. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention.
Choo EH; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
Heart; 2014 Mar; 100(6):492-9. PubMed ID: 24395980
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Stephenson K; Skali H; McMurray JJ; Velazquez EJ; Aylward PG; Kober L; Van de Werf F; White HD; Pieper KS; Califf RM; Solomon SD; Pfeffer MA
Heart Rhythm; 2007 Mar; 4(3):308-13. PubMed ID: 17341394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
